DIALOGUE Study Completes: Digital Platform Shows Promise for Hereditary Cancer Family Communication — Implications for Australian Practice

References

1. 1.University of Basel. (2024). The DIALOGUE Study: Using Digital Health to Improve Care for Families With Predisposition to Hereditary Cancer. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT04214210
2. 2.Suthers, G. K., Armstrong, J., McCormack, J., & Trott, D. (2006). Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder. Journal of Medical Genetics, 43(8), 665-670. https://doi.org/10.1136/jmg.2005.039172
3. 3.Kuchenbaecker, K. B., Hopper, J. L., Barnes, D. R., Phillips, K. A., Mooij, T. M., Roos-Blom, M. J., ... & Olsson, H. (2017). Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA, 317(23), 2402-2416. https://doi.org/10.1001/jama.2017.7112
4. 4.Caswell-Jin, J. L., Zimmer, A. D., Stedden, W., Kingham, K. E., Zhou, A. Y., Kurian, A. W., & Harrington, C. (2019). Cascade genetic testing of relatives for hereditary breast and ovarian cancer: results of an online training course. Journal of Medical Genetics, 56(10), 668-673. https://doi.org/10.1136/jmedgenet-2018-105829
5. 5.National Health and Medical Research Council. (2019). Clinical practice guidelines for the management of women with epithelial ovarian cancer. NHMRC. https://www.nhmrc.gov.au/about-us/publications/clinical-practice-guidelines-management-women-epithelial-ovarian-cancer